Workflow
*ST长药(300391.SZ):2025年中报净利润为-1.16亿元
Xin Lang Cai Jing·2025-08-26 01:58

Core Insights - *ST Changyao reported a total operating revenue of 70.575 million yuan for the first half of 2025, a decrease of 3.0787 million yuan compared to the same period last year, representing a year-on-year decline of 4.18% [1] - The company recorded a net profit attributable to shareholders of -116 million yuan as of June 30, 2025 [1] - Operating cash flow showed a net outflow of -112 million yuan, a decrease of 81.9048 million yuan compared to the same period last year [1] Financial Metrics - As of June 30, 2025, the asset-liability ratio was 128.22%, an increase of 3.21 percentage points from the previous quarter and an increase of 53.18 percentage points year-on-year [3] - The gross profit margin was 3.66%, down 2.01 percentage points compared to the same period last year [3] - The diluted earnings per share were -0.33 yuan [3] - The total asset turnover ratio was 0.04 times, and the inventory turnover ratio was 1.38 times as of June 30, 2025 [3] Shareholder Information - The number of shareholders was 15,900, with the top ten shareholders holding a total of 99.0079 million shares, accounting for 28.26% of the total share capital [3] - The top ten shareholders and their respective holdings are as follows: 1. Changxing Shengshi Zhuhua Investment Co., Ltd. - 10.1 million shares 2. Shanghai Yucong Asset Management Co., Ltd. - 5.95 million shares 3. Liu Lili - 5.05 million shares 4. Shouguang City Kangyue Investment Co., Ltd. - 3.46 million shares 5. Cai Ping - 0.86 million shares 6. Wang Fugeng - 0.66 million shares 7. Shanghai Kaishuang Private Fund Management Co., Ltd. - 0.57 million shares 8. Li Yufang - 0.54 million shares 9. Chen Daoming - 0.51 million shares 10. Chen Zhiming - 0.51 million shares [3]